[Hormone therapy in menopause: when not to use.]

[Hormone therapy in menopause: when not to use.] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Hormone therapy in menopause: when not to use.] Abstract Text:

Poli Mara Spritzer, Wender,Poli Mara Spritzer, Wender,

Menopause is defined as the permanent cessation of menses, as a result of the loss of ovarian follicular function or of surgical removal of ovaries. The mean age for occurrence of natural menopause is around 50 years. Estrogen deficiency has been associated with vasomotor symptoms, urogenital atrophy, and cognitive impairment, as well as increased risk of chronic degenerative diseases such as osteoporosis and Alzheimers disease. Estrogen therapy remains the most effective treatment for the management of vasomotor symptoms and urogenital atrophy. Progesterone or progestins should be added to estrogen treatment in women with uterus, in order to antagonize the estrogen-induced endometrial proliferation. In turn, in specific clinical conditions hormone therapy is not recommended. In the present article, the authors critically focus these clinical conditions in which hormone therapy should not be used.

[Hormone therapy in menopause: when not to use.] Publishing Authors By Initials

PM Spritzer,MC Wender,PM Spritzer,MC Wender,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

[Hormone therapy in menopause: when not to use.] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Arquivos brasileiros de endocrinologia e metabolog

VOLUME: 51

Page Numbers: 1058-63

Journal Abbreviation:

ISSN: 0004-2730

DAY: 24

MONTH: Oct

YEAR: 2007

[Hormone therapy in menopause: when not to use.] Information

Number of References:

LANGUAGE: por

NlmUniqueID: 403437

[Hormone therapy in menopause: when not to use.] Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: [Hormone therapy in menopause: when not to use.] Information

Substance Name:

Registry Number:

Grant and Affiliation Information for [Hormone therapy in menopause: when not to use.]

AFFILIATION: Unidade de Endocrinologia Ginecológica, Serviço de Endocrinologia, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS.

Country: Brazil

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Arq Bras Endocrinol Metabol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Hormone therapy in menopause: when not to use Related Publications

• 3-Hydroxy-2-naphthoic acid as an intermediate in bacterial dissimilation of anthracene.
• A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening.
• Colonoscopy surveillance after polypectomy and colorectal cancer resection.
• Cost-effectiveness of targeted and tailored interventions on colorectal cancer screening use.
• Diversity-invasibility across an experimental disturbance gradient in Appalachian Forests.
• EFFECT OF PNEUMOENCEPHALOGRAPHY ON SERUM LIPIDS.
• Effect of methylprednisolone treatment on expression of sPECAM-1 and CXCL10 chemokine in serum of MS patients.
• Effects of levodopa on attention deficit disorder, residual type.
• Experimental model for the study of chronic renal ischemia in rats: morphologic, histological and ultra-structural analysis.
• Formation of scopoletin from esculin and esculetin in the rat.
• Genetic study of familial cases of Alzheimer's disease.
• How to increase colorectal cancer screening rates in practice.
• Methylnaphthalene oxidations by pseudomonads.
• Nitrous oxide remains a valuable adjuvant for surgery.
• Releasable luciferin-transporter conjugates: tools for the real-time analysis of cellular uptake and release.
• Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells.
• SPECTRAL IDENTIFICATION STUDIES OF PHENOLIC ACIDS USING ALUMINUM CHLORIDE.
• Spontaneous selective attention in schizophrenia.
• THE EFFECT OF IONIZING RADIATION ON PHYSIOLOGICAL CHANGES IN THE CONTENT OF MINERAL COMPONENTS IN THE BRAIN DURING DEVELOPMENT.
• The influence of encephalography on the system of circulation.
• The microbiology of coal. I. Bacterial oxidation of phenanthrene.
• The use of amberlite resin in a separation of xanthine and guanine.
• Topotecan and paclitaxel in previously treated patients with relapsed small cell lung cancer: phase II trial of the North Central Cancer Treatment Group.
• Transition metal-catalyzed intermolecular [5+2] and [5+2+1] cycloadditions of allenes and vinylcyclopropanes.
• Treatment of attention deficit disorder with DL-phenylalanine.
• URINARY PRODUCTS FROM QUERCETIN IN NEOMYCIN-TREATED RATS.
• [Attention deficit hyperactivity disorder in adults : Benchmarking diagnosis using the Wender-Reimherr adult rating scale.]
• [Classification of demyelinizing diseases.]
• [Functional disturbances of the endocrine glands in diseases of the central nervous system.]
• [Hormone therapy in menopause: when not to use.]